Literature DB >> 8153269

Assessing prevention effectiveness using data to drive program decisions.

S B Thacker1, J P Koplan, W R Taylor, A R Hinman, M F Katz, W L Roper.   

Abstract

The measure of the effectiveness of health promotion and disease prevention activities is the impact of prevention policies, programs, and practices on public health and clinical medicine. Assessing prevention effectiveness involves continuing quantitative analysis of health outcomes resulting from prevention practices. Additionally, assessment involves evaluation of disease- and injury-prevention activities, including their medical, legal, ethical, and economic impacts. Although assessing the effectiveness of prevention activities involves measuring efficacy, safety, and cost, the primary criterion is to improve health at a reasonable cost, not merely to contain costs. Policy makers can use the results of assessments to set priorities in public health. The authors use case studies to illustrate various approaches to evaluating prevention programs, including programs for preventing measles, breast cancer, and diabetic retinopathy. Rigorous evaluation of the effectiveness of prevention activities is essential to the wide acceptance of preventive interventions and the willingness to pay for them.

Entities:  

Mesh:

Year:  1994        PMID: 8153269      PMCID: PMC1403474     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  40 in total

1.  Cost-benefits of measles eradication: effects of a federal intervention.

Authors:  R B Albritton
Journal:  Policy Anal       Date:  1978

2.  Effectiveness in health care. An initiative to evaluate and improve medical practice.

Authors:  W L Roper; W Winkenwerder; G M Hackbarth; H Krakauer
Journal:  N Engl J Med       Date:  1988-11-03       Impact factor: 91.245

3.  Epidemiologic basis for eradication of measles in 1967.

Authors:  D J Sencer; H B Dull; A D Langmuir
Journal:  Public Health Rep       Date:  1967-03       Impact factor: 2.792

4.  Assessing the cost-effectiveness of prevention.

Authors:  H D Banta; B R Luce
Journal:  J Community Health       Date:  1983

5.  Diabetic retinopathy in the West of Scotland: its detection and prevalence, and the cost-effectiveness of a proposed screening programme.

Authors:  W S Foulds; A McCuish; T Barrie; F Green; I N Scobie; I M Ghafour; E McClure; J H Barber
Journal:  Health Bull (Edinb)       Date:  1983-11

6.  Diagnosis of diabetic eye disease.

Authors:  E J Sussman; W G Tsiaras; K A Soper
Journal:  JAMA       Date:  1982-06-18       Impact factor: 56.272

7.  Active life expectancy.

Authors:  S Katz; L G Branch; M H Branson; J A Papsidero; J C Beck; D S Greer
Journal:  N Engl J Med       Date:  1983-11-17       Impact factor: 91.245

8.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

9.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

10.  Screening of diabetics for retinopathy by ophthalmic opticians.

Authors:  C J Burns-Cox; J C Hart
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-06
View more
  7 in total

Review 1.  The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance.

Authors:  Mark V Rubertone; John F Brundage
Journal:  Am J Public Health       Date:  2002-12       Impact factor: 9.308

2.  Policy research for disease prevention: challenges and practical recommendations.

Authors:  R C Brownson; C J Newschaffer; F Ali-Abarghoui
Journal:  Am J Public Health       Date:  1997-05       Impact factor: 9.308

Review 3.  Review of electronic decision-support tools for diabetes care: a viable option for low- and middle-income countries?

Authors:  Mohammed K Ali; Seema Shah; Nikhil Tandon
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

4.  20 Years of Public Health Economics and Decision Sciences at the US Centers for Disease Control and Prevention: The CDC Steven M. Teutsch Prevention Effectiveness Fellowship, 1995-2015.

Authors:  Adam G Skelton; Martin I Meltzer
Journal:  J Public Health Manag Pract       Date:  2017 Jul/Aug

5.  Southeastern Title V program staff perceptions of state-level maternal and child health assessment skills.

Authors:  A M Farel; M D Peoples-Sheps; E U Schwarte; C J Waller
Journal:  Matern Child Health J       Date:  1997-12

6.  Using data to plan public health programs: experience from state cancer prevention and control programs.

Authors:  M H Alciati; K Glanz
Journal:  Public Health Rep       Date:  1996 Mar-Apr       Impact factor: 2.792

7.  Prevention praised, cure preferred: results of between-subjects experimental studies comparing (monetary) appreciation for preventive and curative interventions.

Authors:  Ree M Meertens; Vivian M J Van de Gaar; Maitta Spronken; Nanne K de Vries
Journal:  BMC Med Inform Decis Mak       Date:  2013-12-18       Impact factor: 2.796

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.